Home-based cardiac rehabilitation for people living with Heart Failure and their caregivers
OtherIntervention DK:REACH-HF is a home-based 12-week CR program for people living with HF and their caregivers.
NCT Number: NCT06573242
Background: Participation in cardiac rehabilitation (CR) is a strong recommendation of clinical guidelines for the management of heart failure (HF) because it is demonstrated to be a clinically effective and cost-effective intervention. Despite this, Danish data shows the uptake of CR is suboptimal (51%). A major barrier is that the traditional mode of CR provision is centre based. Travelling (time and cost), dislike of group exercise, and inconvenient timings are some key problems to participation. A potential solution is use of home-based programmes as an alternative to traditional CR.
A novel home-based programme for patients with HF and their caregivers (REACH-HF), developed in the United Kingdom has achieved improvements in quality of life and proven to be cost effective. The REACH-HF program is translated and adapted into a Danish context (DK: REACH-HF) and is now ready to be tested in a Danish setting.
The aim of this project is to improve the access and uptake of CR among HF patients in Denmark, particularly in subgroups of patients who currently do not benefit from center-based CR.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Herlev and Gentofte University Hospital, Herlev, Denmark
Globally, Heart Failure (HF) is a common and severe disease affecting millions of people and a major driver of poor health-related quality of life (HRQoL), increased risk of hospitalization and high healthcare costs. Due to the aging of the population as well as the improvements of life-prolonging cardiovascular invasive and medical treatments, the prevalence of patients living with HF is increasing and as many as 1 in 5 people are expected to develop HF during their lifetime. Cardiac rehabilitation (CR) for people living with HF has been demonstrated to be clinically efficacious and cost-effective by improving HRQoL and reducing the risk of hospital readmission. Guidelines therefore strongly recommend CR for people living with HF. However, the uptake and provision of CR for people with HF in Denmark is suboptimal with only 51 % of HF patients participating. Furthermore, there is evidence of social inequality in both referral and participation rates. Reasons for low uptake are complex, but a major barrier is that traditional mode of CR provision is center based. Barriers to center-based programs for patients include travel time and costs and dislike of group sessions. A key potential solution is therefore greater use of alternative modes of CR delivery.
Developed in the UK, 'Rehabilitation EnAblement in CHronic Heart Failure' REACH-HF is an evidence- and theory-based, patient-centred self-care home-based support program co-developed with patients, caregivers, and clinicians to meet the above challenges. Evaluated in the multicenter randomized controlled trial, participation in the REACH-HF programme has shown improved HRQoL for patients with HF and to be cost-effective in a UK healthcare setting. Furthermore, caregivers increased their confidence in the caregiver role. The REACH-HF is now being rolled out routinely across the UK National Health Service, improving CR access for people with HF and their caregivers. Including the core components of comprehensive CR, the REACH-HF program aligns with Danish guidelines. As part of the DK:REACH-HF project, the REACH-HF program and its materials have been translated and adapted into a Danish context. This adaptation process included the consideration of contextual differences between the healthcare systems, legislation, and culture of UK and Denmark and was informed by interviews with leaders and experts in cardiology, healthcare professionals working with HF in both hospital and municipality settings, as well as caregivers and patients. Following this evidence-based approach, the DK:REACH-HF is now ready to be assessed for its feasibility and acceptability to inform wider implementation for Danish patients with HF and their caregivers.
To investigate the feasibility of the DK:REACH-HF program the investigators will employ a single-arm, pre-post mixed methods design with a parallel process evaluation across two-three sites in Denmark. This will involve hospital centers and where applicable local municipalities where the DK:REACH-HF program will be delivered as an alternative to usual care.
The investigators intend to recruit a total of 75 HF patients and their caregivers where applicable, who will each receive the DK:REACH-HF programme delivered by a team of one or two trained intervention-facilitators.
DK:REACH-HF is a home-based 12-week CR program for people living with HF and their caregivers.
Intervention: Patients (and where applicable, caregivers) will be provided with the DK: REACH-HF manuals or/and a digital mobile phone application (Mobile app: "Mit Liv" My Life, translated) based on their preference and consist of four core elements.
The "REACH-HF manual" for patients that includes a detailed information on how to live with HF including topics as: the understanding of what HF is, managing symptom monitoring, information about managing medications, managing breathlessness and anxiety, and a choice of two structured progressive exercise programmes (a walking or/and a chair-based programme).
A Patient "Progress Tracker": an interactive booklet designed to facilitate learning from experience to record daily physical activity, symptoms, weight, and fluid monitoring etc.
The" Family and Friends Resource": a manual for caregivers aimed to increase their understanding of HF and focus on their own physical and mental health and wellbeing.
A two-day course for facilitators who will tailor the intervention for patients and caregivers.
Quantitative data.
Given the pilot nature of the study, the focus of statistical analysis and data presentation will take a descriptive approach for baseline demographic and outcome data. Continuous data will be reported as means ± standard deviation or percentage. Categorical data will be reported as frequencies and percentages. Pre-post-differences in outcomes will be reported as means and 95% confidence intervals.
Qualitative data.
A semi structured interview guide will be used in the process evaluation and will focus on topics such as practical issues managing the DK:REACH-HF intervention program from both a facilitator and participant perspective, delivery of the intervention, participant experience of the intervention etc. The transcribed qualitative data will be coded using NVivo and analyzed using qualitative thematic analysis as described by Braun and Clark.
Mixed methods
The investigators will use both qualitative and quantitative data to gain a more complete and deeper understanding of issues relating to homebased CR for people living with HF and their caregivers as well as for health care providers included as facilitators in the study. By using a mixed methods approach to answer the aim of this research the investigators believe it can be examined in a more nuanced way.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention DK:REACH-HF is a home-based 12-week CR program for people living with HF and their caregivers.
Time frame: 12 weeks
Questionnaire. The MLHFQ is a disease-specific questionnaire for patients with Heart failure, comprising 21 items rated on six-point Likert scales, represening, from 0 (none) to 5 (very much). It provides a total score (range 0-105) Higher scores means worse health related quality of life (HRQoL).
Time frame: 12 weeks
Generic Health related quality of life. Questionnaire. comprises five dimensions, describing different aspect of health: mobility, self-care, usual activities, pain / discomfort and anxiety / depression. Each dimension has five response levels: (1) no problems,(2) slight problems, (3) moderate problems, (4) severe problems, (5) unable to/extreme. Higher scores means worse generic health related quality of life.
Time frame: 12 weeks
Questionnaire. Minimum Value: 0 Maximum Value: 21 (for each subscale: anxiety and depression; the total score can range from 0 to 42) Higher Scores Mean: Worse anxiety or depression. HADS assesses levels of anxiety and depression through separate subscales for each condition
Time frame: 12 weeks
Questionnaire: comprising 12 items rated on a 5-point scale between 1 (I completely agree) and 5 (I completely disagree). Higher score means worse heart failure self-care behaviour
Time frame: 12 weeks
Questionnaire. The KCCQ-12 is a 12-item questionnaire that measures physical function, symptoms, social function, and quality of life. Each Item responses are coded in sequential order (1, 2, 3, etc.) from the worst to the best status. Higher score means better status.
Time frame: 12 weeks
Questionnaire. The caregiver contribution to self-care consist of 10 items devided into 3 scales and uses a 4-point Likert scale (neveror rarely, sometimes, frequently, always or daily). Higher scores means higher contribution to self-care
Time frame: 12 weeks
Questionnaire. The Caregiver burden scale consist of 22 items devided into 5 scales and uses a 4 -point Likert scale rating from 1: "not at all" to 4: "very much". Higher scores means higher degree of burden.
Contact information is provided by the study sponsor or research team.
Malene Hammer Hansen, Master degree
CONTACT
Signe Stelling Stelling Risom, senior researcher
CONTACT
Herlev and Gentofte Hospital
Other
Home-based Cardiac Rehabilitation for People Living With Heart Failure and Their Caregivers- The DK: REACH-HF Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07081711
Aortic Diseases, Arrhythmias, Cardiac
Cleveland, Ohio, United States
View Trial DetailsNCT07592494
Cardiac Resynchronization Therapy Devices, Cardiovascular Diseases
Çorum, Turkey (Türkiye)
View Trial DetailsNCT07574593
Cardiovascular Diseases, Heart Diseases
Chula Vista, California, United States
View Trial DetailsNCT07278583
Cardiovascular Diseases, Heart Diseases
Clermont-Ferrand, France
View Trial Details